HHEX and liver cancer: In contrast to the downregulation and aberrant nuclear localization of HHEX identified in breast, prostate, and liver cancers, we found that HHEX is upregulated during the progression of CRC and that an elevated expression level of HHEX is correlated with poor prognosis in CRC patients.